Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$206.39 - $268.73 $1,238 - $1,612
-6 Reduced 0.53%
1,131 $233,000
Q1 2024

Apr 01, 2024

SELL
$203.52 - $273.43 $4,070 - $5,468
-20 Reduced 1.73%
1,137 $308,000
Q4 2023

Jan 04, 2024

SELL
$164.52 - $238.84 $2,796 - $4,060
-17 Reduced 1.45%
1,157 $273,000
Q3 2023

Oct 10, 2023

SELL
$194.44 - $217.61 $6,805 - $7,616
-35 Reduced 2.89%
1,174 $230,000
Q2 2023

Jul 03, 2023

SELL
$183.71 - $210.25 $2,388 - $2,733
-13 Reduced 1.06%
1,209 $254,000
Q1 2023

Apr 11, 2023

SELL
$191.89 - $259.92 $145,452 - $197,019
-758 Reduced 38.28%
1,222 $247,000
Q1 2020

Apr 16, 2020

SELL
$98.9 - $178.34 $16,516 - $29,782
-167 Reduced 7.78%
1,980 $250,000
Q4 2019

Jan 17, 2020

SELL
$126.05 - $152.76 $6,302 - $7,638
-50 Reduced 2.28%
2,147 $328,000
Q3 2019

Nov 13, 2019

SELL
$125.07 - $143.67 $7,879 - $9,051
-63 Reduced 2.79%
2,197 $291,000
Q2 2019

Jul 19, 2019

SELL
$123.4 - $148.55 $11,723 - $14,112
-95 Reduced 4.03%
2,260 $321,000
Q1 2019

Apr 25, 2019

SELL
$104.82 - $146.73 $26,729 - $37,416
-255 Reduced 9.77%
2,355 $342,000
Q4 2018

Feb 06, 2019

SELL
$105.09 - $137.23 $45,714 - $59,695
-435 Reduced 14.29%
2,610 $295,000
Q3 2018

Nov 02, 2018

SELL
$112.11 - $134.54 $8,296 - $9,955
-74 Reduced 2.37%
3,045 $410,000
Q2 2018

Aug 03, 2018

BUY
$102.37 - $117.25 $2,354 - $2,696
23 Added 0.74%
3,119 $350,000
Q1 2018

May 09, 2018

BUY
$98.19 - $115.2 $303,996 - $356,659
3,096 New
3,096 $330,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.7B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Canandaigua National Bank & Trust CO Portfolio

Follow Canandaigua National Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Bank & Trust CO with notifications on news.